Agenda

Return

C. 64

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	March 22, 2022

Contra

Costa

County

Subject:

Amendment to Purchase Order with McKesson Medical Surgical, Inc. (PO #19324)

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 03/22/2022

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:

Ronny Leffel, (925) 550-2299

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: March 22, 2022
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, an amendment to Purchase Order #19324 with McKesson Medical Surgical, Inc., to increase the payment limit by $166,000 to a new payment limit of $365,000 to procure reagents, equipment, and supplies for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) with no change in the original term of July 1, 2020 through June 30, 2022.

FISCAL IMPACT:

This purchase order amendment will result in additional expenditures of up to $166,000 and is 100% funded by the American Rescue Plan Act (ARPA).

BACKGROUND:

McKesson Medical Surgical, Inc. has provided CCRMC with medical equipment and supplies since 2007. With the increase of COVID patients, the Hospital experienced an increased volume in the use of reagents and other medical supplies. McKesson has been able to backfill the hospital with supplies to maintain operations when we have been placed on backorder status with other vendors. For the past seven (7) months our expenses have been averaging approximately $17,000 per month.

CONSEQUENCE OF NEGATIVE ACTION:

If this contract is not approved CCRMC will be unable to consistently purchase the necessary proprietary reagents to operate the laboratory systems. Additionally, stockouts of critical medical supplies will continue to increase due to limited supply allocations. This will impact the physician’s ability to initiate timely treatment protocols for their patients and could place patients at risk.